Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature
- PMID: 9744703
Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature
Abstract
A 72-year-old housewife presented with clinical and laboratory signs of acute cholestatic hepatitis. Symptoms had appeared 6 months after she was started on ticlopidine 250 mg/day. Infectious aetiologies were excluded by serology and there was no history of alcohol abuse or use of other drugs. Clinical findings were confirmed by liver biopsy. The drug was discontinued and symptoms gradually subsided. A second biopsy obtained during this phase documented complete resolution of the hepatic damage. A review of the literature shows that the late onset of hepatic toxicity in this case is unique and this is the first report to include histological documentation during the acute phase and after recovery.
Similar articles
-
[Ticlopidine-induced cholestatic hepatitis. A case report].Rev Esp Enferm Dig. 1995 Oct;87(10):735-7. Rev Esp Enferm Dig. 1995. PMID: 8519541 Spanish.
-
[Ticlopidine-induced acute cholestatic hepatitis. A case report].Recenti Prog Med. 2004 Feb;95(2):96-9. Recenti Prog Med. 2004. PMID: 15072394 Italian.
-
Severe ticlopidine-induced cholestatic syndrome.Blood Purif. 2007;25(5-6):441-5. doi: 10.1159/000111033. Epub 2007 Nov 14. Blood Purif. 2007. PMID: 18004066
-
[Cholestatic hepatitis caused by glybenclamide in a patient with hepatitis C virus].Rev Esp Enferm Dig. 1995 Feb;87(2):174-6. Rev Esp Enferm Dig. 1995. PMID: 7748712 Review. Spanish.
-
[Acute cholestatic hepatitis caused by propafenone. Report of a case and review of the literature].Recenti Prog Med. 2001 Mar;92(3):197-9. Recenti Prog Med. 2001. PMID: 11320851 Review. Italian.
Cited by
-
Comparison of in vitro metabolism of ticlopidine by human cytochrome P450 2B6 and rabbit cytochrome P450 2B4.Drug Metab Dispos. 2011 Mar;39(3):539-50. doi: 10.1124/dmd.110.037101. Epub 2010 Dec 14. Drug Metab Dispos. 2011. PMID: 21156812 Free PMC article.
-
Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report.J Med Case Rep. 2010 Aug 12;4:269. doi: 10.1186/1752-1947-4-269. J Med Case Rep. 2010. PMID: 20704700 Free PMC article.
-
A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: a report of two new cases of ticlopidine-induced hepatotoxicity.Drug Saf. 2002;25(10):735-50. doi: 10.2165/00002018-200225100-00006. Drug Saf. 2002. PMID: 12167069
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical